Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2014

Open Access 01-12-2014 | Review

Early life programming as a target for prevention of child and adolescent mental disorders

Authors: Andrew James Lewis, Megan Galbally, Tara Gannon, Christos Symeonides

Published in: BMC Medicine | Issue 1/2014

Login to get access

Abstract

This paper concerns future policy development and programs of research for the prevention of mental disorders based on research emerging from fetal and early life programming. The current review offers an overview of findings on pregnancy exposures such as maternal mental health, lifestyle factors, and potential teratogenic and neurotoxic exposures on child outcomes. Outcomes of interest are common child and adolescent mental disorders including hyperactive, behavioral and emotional disorders. This literature suggests that the preconception and perinatal periods offer important opportunities for the prevention of deleterious fetal exposures. As such, the perinatal period is a critical period where future mental health prevention efforts should be focused and prevention models developed. Interventions grounded in evidence-based recommendations for the perinatal period could take the form of public health, universal and more targeted interventions. If successful, such interventions are likely to have lifelong effects on (mental) health.
Literature
1.
Barker DJ: The developmental origins of chronic adult disease. Acta Paediatrica. 2004, 93: 26-33.PubMed
2.
Belfer ML: Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry. 2008, 49: 226-236. 10.1111/j.1469-7610.2007.01855.x.PubMed
3.
Ravens-Sieberer U, Wille N, Erhart M, Bettge S, Wittchen HU, Rothenberger A, Herpertz-Dahlmann B, Resch F, Holling H, Bullinger M, Barkmann C, Schulte-Markwort M, Dopfner M, BELLA study group: Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey. Eur Child Adolesc Psychiatry. 2008, 17: 22-33. 10.1007/s00787-008-1003-2.PubMed
4.
Sawyer MG, Arney FM, Baghurst PA, Clarke JJ, Graetz BW, Kosky RJ, Nurcomber B, Patton GC, Prior MR, Raphael B, et al: The mental health of young people in Australia-key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry. 2001, 35: 806-814. 10.1046/j.1440-1614.2001.00964.x.PubMed
5.
Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS: Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics. 2010, 125: 75-81. 10.1542/peds.2008-2598.PubMed
6.
Meltzer H: Childhood mental disorders in Great Britain: an epidemiological perspective. Child Care Pract. 2007, 13: 313-326. 10.1080/13575270701488683.
7.
Rescorla L, Achenbach TM, Ivanova MY, Dumenci L, Almqvist F, Bilenberg N, Bird H, Broberg A, Dobrean A, Dopfner M, et al: Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countries. J Consult Clin Psychol. 2007, 75: 351-358.PubMed
8.
Angold A, Costello EJ, Worthman CM: Puberty and depression- the roles of age, pubertal status and pubertal timing. Psychol Med. 1998, 28: 51-61. 10.1017/S003329179700593X.PubMed
9.
Mueller BR, Bale TL: Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci. 2008, 28: 9055-9065. 10.1523/JNEUROSCI.1424-08.2008.PubMedPubMedCentral
10.
Barker DJ: The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc Biol Sci. 1995, 262: 37-43. 10.1098/rspb.1995.0173.PubMed
11.
Gluckman PD, Hanson MA: The developmental origins of health and disease: the breadth and importance of the concept. Early Life Origins of Health and Disease. Edited by: Wintour EM, Owens JA. 2006, New York, NY: Springer Science + Business Media
12.
Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O, Rohde LA, Srinath S, Ulkuer N, Rahman A: Child and adolescent mental health worldwide: evidence for action. Lancet. 2011, 378: 1515-1525. 10.1016/S0140-6736(11)60827-1.PubMed
13.
Stearns SC, Koella JC: The evolution of phenotypic plasticity in life-history traits: predictions of reaction norms for age and size at maturity. Evolution. 1986, 40: 893-913. 10.2307/2408752.
14.
Gluckman PD, Hanson MA, Beedle AS: Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol. 2007, 19: 1-19. 10.1002/ajhb.20590.PubMed
15.
West-Eberhard MJ: Developmental Plasticity and Evolution. 2003, Oxford: Oxford University Press
16.
Gluckman PD, Hanson MA, Bateson P, Beedle AS, Law CM, Bhutta ZA, Anokhin KV, Bougnères P, Chandak GR, Dasgupta P, et al: Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet. 2009, 373: 1654-1657. 10.1016/S0140-6736(09)60234-8.PubMed
17.
Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley R, Gluckman P, Godfrey K, Kirkwood T, Lahr M: Developmental plasticity and human health. Nature. 2004, 430: 419-421. 10.1038/nature02725.PubMed
18.
Gluckman PD, Hanson MA: The conceptual basis for the developmental origins of health and disease. Developmental Origins of Health and Disease. Edited by: Gluckman PD, Hanson MA. 2006, New York: Cambridge University Press, 33-50.
19.
Ollikainen M, Smith KR, Joo EJ-H, Ng HK, Andronikos R, Novakovic B, Aziz NKA, Carlin JB, Morley R, Saffery R: DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet. 2010, 19: 4176-4188. 10.1093/hmg/ddq336.PubMed
20.
Meaney MJ, Szyf M, Seckl JR: Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med. 2007, 13: 269-277. 10.1016/j.molmed.2007.05.003.PubMed
21.
Schlotz W, Phillips DI: Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun. 2009, 23: 905-916. 10.1016/j.bbi.2009.02.001.PubMed
22.
Whitelaw E, Garrick D: Epigenetic mechanisms. Developmental Origins of Health and Disease. Edited by: Gluckman PD, Hanson MA. 2006, New York: Cambridge University Press, 62-74.
23.
Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R, Craig JM: Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. Genome Biol. 2013, 14: R42-10.1186/gb-2013-14-5-r42.PubMedPubMedCentral
24.
Barker DJ, Osmond C, Rodin I, Fall C, Winter P: Low weight gain in infancy and suicide in adult life. BMJ. 1995, 311: 1203-10.1136/bmj.311.7014.1203.PubMedPubMedCentral
25.
Talge NM, Neal C, Glover V: Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry. 2007, 48: 245-261. 10.1111/j.1469-7610.2006.01714.x.PubMed
26.
Swanson JD, Wadhwa PM: Developmental origins of child mental health disorders. J Child Psychol Psychiatry. 2008, 49: 1009-1019. 10.1111/j.1469-7610.2008.02014.x.PubMedPubMedCentral
27.
Lupien SJ, McEwen BS, Gunnar MR, Heim C: Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009, 10: 434-445. 10.1038/nrn2639.PubMed
28.
Bolt R, Van Weissenbruch M, Lafeber H, Delemarre-Van de Waal H: Development of the hypothalamic-pituitary-adrenal axis in the fetus and preterm infant. J Pediatr Endocrinol Metab. 2002, 15: 759-770.PubMed
29.
Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Patel F, Whittle W, Fraser M, Moss T, Newnham J: The fetal placental hypothalamic–pituitary–adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol. 2001, 185: 135-144. 10.1016/S0303-7207(01)00624-4.PubMed
30.
De Kloet ER, Joëls M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005, 6: 463-475. 10.1038/nrn1683.PubMed
31.
Phillips DI, Jones A: Fetal programming of autonomic and HPA function: do people who were small babies have enhanced stress responses?. J Physiol. 2006, 572: 45-50.PubMedPubMedCentral
32.
Price D, Close G, Fielding B: Age of appearance of circadian rhythm in salivary cortisol values in infancy. Arch Dis Child. 1983, 58: 454-456. 10.1136/adc.58.6.454.PubMedPubMedCentral
33.
Gunnar M, Quevedo K: The neurobiology of stress and development. Annu Rev Psychol. 2007, 58: 145-173. 10.1146/annurev.psych.58.110405.085605.PubMed
34.
Cottrell EC, Seckl JR: Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci. 2009, 3: 1-9.
35.
O'donnell K, O'connor T, Glover V: Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Dev Neurosci. 2009, 31: 285-292. 10.1159/000216539.PubMed
36.
Monk C, Spicer J, Champagne FA: Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol. 2012, 24: 1361-1376. 10.1017/S0954579412000764.PubMedPubMedCentral
37.
Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF, Stowe ZN: DNA methylation in neonates born to women receiving psychiatric care. Epigenetics. 2012, 7: 409-414. 10.4161/epi.19551.PubMedPubMedCentral
38.
Smith AK, Conneely KN, Newport DJ, Kilaru V, Schroeder JW, Pennell PB, Knight BT, Cubells JC, Stowe ZN, Brennan PA: Prenatal antiepileptic exposure associates with neonatal DNA methylation differences. Epigenetics. 2012, 7: 458-463. 10.4161/epi.19617.PubMedPubMedCentral
39.
Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM: Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics. 2008, 3: 97-106. 10.4161/epi.3.2.6034.PubMed
40.
Nathanielsz PW, Nathanielsz P: Life in the Womb: The Origin of Health and Disease. 1999, Ithaca, NY: Promethean Press
41.
Barker DJ: Maternal nutrition, fetal nutrition, and disease in later life. Nutrition. 1997, 13: 807-813. 10.1016/S0899-9007(97)00193-7.PubMed
42.
Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES: Early life programming and neurodevelopmental disorders. Biol Psychiatry. 2010, 68: 314-319. 10.1016/j.biopsych.2010.05.028.PubMedPubMedCentral
43.
Sullivan EL, Grayson B, Takahashi D, Robertson N, Maier A, Bethea CL, Smith MS, Coleman K, Grove KL: Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J Neurosci. 2010, 30: 3826-3830. 10.1523/JNEUROSCI.5560-09.2010.PubMedPubMedCentral
44.
Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM: Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology. 2010, 151: 4756-4764. 10.1210/en.2010-0505.PubMedPubMedCentral
45.
Jacka FN, Ystrom E, Brantsaeter AL, Karevold E, Roth C, Haugen M, Meltzer HM, Schjolberg S, Berk M: Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatr. 2013, 52: 1038-1047. 10.1016/j.jaac.2013.07.002.
46.
Keenan K, Bartlett TQ, Nijland M, Rodriguez JS, Nathanielsz PW, Zürcher NR: Poor nutrition during pregnancy and lactation negatively affects neurodevelopment of the offspring: evidence from a translational primate model. Am J Clin Nutr. 2013, 98: 396-402. 10.3945/ajcn.112.040352.PubMedPubMedCentral
47.
Rodriguez A: Maternal pre‒pregnancy obesity and risk for inattention and negative emotionality in children. J Child Psychol Psychiatry. 2010, 51: 134-143. 10.1111/j.1469-7610.2009.02133.x.PubMed
48.
Van Lieshout RJ, Taylor VH, Boyle MH: Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review. Obes Rev. 2011, 12: e548-e559. 10.1111/j.1467-789X.2010.00850.x.PubMed
49.
Goodman SH, Gotlib IH: Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev. 1999, 106: 458-490.PubMed
50.
Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ: A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010, 67: 1012-10.1001/archgenpsychiatry.2010.111.PubMedPubMedCentral
51.
Murray L, Halligan SL, Goodyer I, Herbert J: Disturbances in early parenting of depressed mothers and cortisol secretion in offspring: a preliminary study. J Affect Disord. 2010, 122: 218-223. 10.1016/j.jad.2009.06.034.PubMed
52.
Bagner DM, Pettit JW, Lewinsohn PM, Seeley JR: Effect of maternal depression on child behavior: a sensitive period?. J Am Acad Child Adolesc Psychiatry. 2010, 49: 699-707.PubMedPubMedCentral
53.
Bureau JF, Easterbrooks MA, Lyons-Ruth K: Maternal depressive symptoms in infancy: unique contribution to children's depressive symptoms in childhood and adolescence?. Dev Psychopathol. 2009, 21: 519-537. 10.1017/S0954579409000285.PubMedPubMedCentral
54.
Dawson G, Klinger LG, Panagiotides H, Hill D, Spieker S: Frontal lobe activity and affective behavior of infants of mothers with depressive symptoms. Child Dev. 1992, 63: 725-737. 10.2307/1131357.PubMed
55.
Tronick EZ: Emotions and emotional communication in infants. Am Psychol. 1989, 44: 112-119.PubMed
56.
Field T: Maternal depression effects on infants and early interventions. Prev Med. 1998, 27: 200-203. 10.1006/pmed.1998.0293.PubMed
57.
Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI: Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol. 1989, 57: 269-274.PubMed
58.
O'Hara MW, Swain AM: Rates and risk of postpartum degression - a meta-analysis. Int Rev Psychiatry. 1996, 8: 37-54. 10.3109/09540269609037816.
59.
Martins C, Gaffan EA: Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry. 2000, 41: 737-746. 10.1111/1469-7610.00661.PubMed
60.
Weinstock M: The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun. 2005, 19: 296-308. 10.1016/j.bbi.2004.09.006.PubMed
61.
Van den Bergh BRH, Marcoen A: High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev. 2004, 75: 1085-1097. 10.1111/j.1467-8624.2004.00727.x.PubMed
62.
Bergman K, Sarkar P, Glover V, O'Connor TG: Maternal prenatal cortisol and infant cognitive development: moderation by infant-mother attachment. Biol Psychiatry. 2010, 67: 1026-1032. 10.1016/j.biopsych.2010.01.002.PubMedPubMedCentral
63.
Lewis AJ, Olsson CA: Early life stress and child temperament style as predictors of childhood anxiety and depressive symptoms: findings from the longitudinal study of Australian children. Depress Res Treat. 2011, 2012: 1-9.
64.
Kaplan LA, Evans L, Monk C: Effects of mothers’ prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified?. Early Hum Dev. 2008, 84: 249-256. 10.1016/j.earlhumdev.2007.06.004.PubMed
65.
O'Connor TG, Heron J, Golding J, Beveridge M, Glover V: Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years: report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry. 2002, 180: 502-508. 10.1192/bjp.180.6.502.PubMed
66.
Van den Bergh BRH, van Calster B, Smits T, van Huffel S, Lagae L: Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology. 2008, 33: 536-545. 10.1038/sj.npp.1301450.PubMed
67.
Glover V: Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective. J Child Psychol Psychiatry. 2011, 52: 356-367. 10.1111/j.1469-7610.2011.02371.x.PubMed
68.
Van den Bergh BR, Mulder EJ, Mennes M, Glover V: Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev. 2005, 29: 237-258. 10.1016/j.neubiorev.2004.10.007.PubMed
69.
Räikkönen K, Seckl J, Pesonen A-K, Simons A, Van den Bergh B: Stress, glucocorticoids and liquorice in human pregnancy: programmers of the offspring brain. Stress. 2011, 14: 590-603.PubMed
70.
Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry. 2008, 65: 146-152. 10.1001/archgenpsychiatry.2007.20.PubMed
71.
Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J: Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatr Scand. 2004, 110: 356-364. 10.1111/j.1600-0447.2004.00429.x.PubMed
72.
Kinney DK, Miller AM, Crowley DJ, Huang E, Gerber E: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord. 2008, 38: 481-488. 10.1007/s10803-007-0414-0.PubMed
73.
Watson JB, Mednick SA, Huttunen M, Wang X: Prenatal teratogens and the development of adult mental illness. Dev Psychopathol. 1999, 11: 457-466. 10.1017/S0954579499002151.PubMed
74.
Loomans EM, van der Stelt O, van Eijsden M, Gemke RJBJ, Vrijkotte T, van den Bergh BR: Antenatal maternal anxiety is associated with problem behaviour at age five. Early Hum Dev. 2011, 87: 565-570. 10.1016/j.earlhumdev.2011.04.014.PubMed
75.
O'Connor TG, Heron J, Golding J, Glover V, the ALSPAC Study Team: Maternal antenatal anxiety and behavioural/ emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry. 2003, 44: 1025-1036. 10.1111/1469-7610.00187.PubMed
76.
Clavarino AM, Mamun AA, O'Callaghan M, Aird R, Bor W, O'Callaghan F, Williams GM, Marrington S, Najman JM, Alati R: Maternal anxiety and attention problems in children at 5 and 14 years. J Atten Disord. 2010, 13: 658-667. 10.1177/1087054709347203.PubMed
77.
Robinson M, Oddy WH, Li J, Kendall GE, de Klerk NH, Silburn SR, Zubrick SR, Newnham JP, Stanley FJ, Mattes E: Pre- and postnatal influences on preschool mental health: a large-scale cohort study. J Child Psychol Psychiatry. 2008, 49: 1118-1128. 10.1111/j.1469-7610.2008.01955.x.PubMed
78.
Mayes LC, Ward A: Principles of neurobehavioral teratology. Neurodevelopmental Mech Psychopathol. 2003, 3-33.
79.
Obican S, Scialli AR: Teratogenic exposures. Am J Med Genet C Semin Med Genet. 2011, 157C: 150-169.PubMed
80.
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee D-H, Shioda T, Soto AM, vom Saal FS, Welshons WV: Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012, 33: 378-455. 10.1210/er.2011-1050.PubMedPubMedCentral
81.
Lewis MW, Misra S, Johnson HL, Rosen TS: Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months. Am J Drug Alcohol Abuse. 2004, 30: 299-320. 10.1081/ADA-120037380.PubMed
82.
McDonald SD, Walker M, Perkins SL, Beyene J, Murphy K, Gibb W, Ohlsson A: The effect of tobacco exposure on the fetal hypothalamic-pituitary-adrenal axis. Bjog. 2006, 113: 1289-1295. 10.1111/j.1471-0528.2006.01089.x.PubMed
83.
Stene-Larsen K, Borge AIH, Vollrath ME: Maternal smoking in pregnancy and externalizing behavior in 18-month-old children: results from a population-based prospective study. J Am Acad Child Adolesc Psychiatr. 2009, 48: 283-289. 10.1097/CHI.0b013e318195bcfb.
84.
Lester BM, Bagner DM, Liu J, LaGasse LL, Seifer R, Bauer CR, Shankaran S, Bada H, Higgins RD, Das A: Infant neurobehavioral dysregulation: behavior problems in children with prenatal substance exposure. Pediatrics. 2009, 124: 1355-1362. 10.1542/peds.2008-2898.PubMedPubMedCentral
85.
Ebrahim SH, Floyd RL, Merritt RK, Decoufle P, Holtzman D: Trends in pregnancy-related smoking rates in the United States, 1987–1996. JAMA. 2000, 283: 361-366. 10.1001/jama.283.3.361.PubMed
86.
Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA: Alcohol consumption by women before and during pregnancy. Matern Child Health J. 2009, 13: 274-285. 10.1007/s10995-008-0328-2.PubMed
87.
Cooper WO, Willy ME, Pont SJ, Ray WA: Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007, 196: 544.PubMed
88.
Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD: The decline in blood lead levels in the United States. JAMA. 1994, 272: 284-291. 10.1001/jama.1994.03520040046039.PubMed
89.
Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR: Maternal lifestyle factors in pregnancy risk of ADHD. Am J Psychiatr. 2003, 160: 1028-1040. 10.1176/appi.ajp.160.6.1028.PubMed
90.
Rodriguez A, Bohlin G: Are maternal smoking and stress during pregnancy related to ADHD symptoms in children?. J Child Psychol Psychiatry. 2005, 46: 246-254. 10.1111/j.1469-7610.2004.00359.x.PubMed
91.
Tiesler CM, Chen CM, Sausenthaler S, Herbarth O, Lehmann I, Schaaf B, Kramer U, von Berg A, von Kries R, Wichmann HE, Heinrich J: Passive smoking and behavioural problems in children: results from the LISAplus prospective birth cohort study. Environ Res. 2011, 111: 1173-1179. 10.1016/j.envres.2011.06.011.PubMed
92.
Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP: Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006, 114: 1904-1909.PubMedPubMedCentral
93.
Brion MJ, Victora C, Matijasevich A, Horta B, Anselmi L, Steer C, Menezes AM, Lawlor DA, Davey Smith G: Maternal smoking and child psychological problems: disentangling causal and noncausal effects. Pediatrics. 2010, 126: e57-e65. 10.1542/peds.2009-2754.PubMedPubMedCentral
94.
Hsieh CJ, Jeng SF, Su YN, Liao HF, Hsieh WS, Wu KY, Chen PC: CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior. Nicotine Tob Res. 2010, 12: 1108-1117. 10.1093/ntr/ntq157.PubMed
95.
Liu J, Leung PW, McCauley L, Ai Y, Pinto-Martin J: Mother's environmental tobacco smoke exposure during pregnancy and externalizing behavior problems in children. Neurotoxicology. 2013, 34: 167-174.PubMed
96.
Twardella D, Bolte G, Fromme H, Wildner M, von Kries R: Exposure to secondhand tobacco smoke and child behaviour - results from a cross-sectional study among preschool children in Bavaria. Acta Paediatr. 2010, 99: 106-111.PubMed
97.
Ruckinger S, Rzehak P, Chen CM, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Kramer U, Berdel D, von Berg A, et al: Prenatal and postnatal tobacco exposure and behavioral problems in 10-year-old children: results from the GINI-plus prospective birth cohort study. Environ Health Perspect. 2010, 118: 150-154.PubMed
98.
Langley K, Heron J, Smith GD, Thapar A: Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am J Epidemiol. 2012, 176: 261-268. 10.1093/aje/kwr510.PubMedPubMedCentral
99.
Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G: Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry. 2009, 66: 722-727. 10.1016/j.biopsych.2009.05.032.PubMedPubMedCentral
100.
Buschgens CJ, Swinkels SH, van Aken MA, Ormel J, Verhulst FC, Buitelaar JK: Externalizing behaviors in preadolescents: familial risk to externalizing behaviors, prenatal and perinatal risks, and their interactions. Eur Child Adolesc Psychiatry. 2009, 18: 65-74. 10.1007/s00787-008-0704-x.PubMed
101.
Streissguth AP, Barr HM, Sampson PD: Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res. 1990, 14: 662-669. 10.1111/j.1530-0277.1990.tb01224.x.PubMed
102.
Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, Janisse J, Martier S, Sokol RJ: Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose–response effect. Pediatrics. 2001, 108: e34-e34. 10.1542/peds.108.2.e34.PubMed
103.
Bada HS, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, Hammond J, Wright LL, Higgins R: Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics. 2007, 119: e348-e359. 10.1542/peds.2006-1404.PubMed
104.
Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H: Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr. 2005, 26: 42-47.PubMed
105.
LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Danereau L, Lester BM: Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 2012, 129: 681-688. 10.1542/peds.2011-2209.PubMedPubMedCentral
106.
Goldschmidt L, Day NL, Richardson GA: Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000, 22: 325-336. 10.1016/S0892-0362(00)00066-0.PubMed
107.
Day NL, Leech SL, Goldschmidt L: The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicol Teratol. 2011, 33: 129-136. 10.1016/j.ntt.2010.07.006.PubMedPubMedCentral
108.
Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R: Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008, 198: 194-e191-195PubMed
109.
Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C: Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006, 63: 898-906. 10.1001/archpsyc.63.8.898.PubMed
110.
Lewis AJ, Bailey C, Galbally M: Anti-depressant use during pregnancy in Australia: findings from the Longitudinal Study of Australian Children. Aust N Z J Public Health. 2012, 36: 487-488. 10.1111/j.1753-6405.2012.00917.x.PubMed
111.
Malm H, Artama M, Gissler M, Ritvanen A: Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011, 118: 111-10.1097/AOG.0b013e318220edcc.PubMed
112.
Galbally M, Roberts M, Buist A: Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry. 2010, 44: 967-977.PubMed
113.
Einarson A, Boskovic R: Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract. 2009, 15: 183-192. 10.1097/01.pra.0000351878.45260.94.PubMed
114.
Einarson A, Einarson TR: Maternal use of antipsychotics in early pregnancy: little evidence of increased risk of congenital malformations. Evid Based Ment Health. 2009, 12: 29-10.1136/ebmh.12.1.29.PubMed
115.
Gentile S: Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects. Acta Psychiatr Scand. 2011, 123: 266-275. 10.1111/j.1600-0447.2011.01673.x.PubMed
116.
Gentile S, Galbally M: Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affect Disord. 2010, 128: 1-9.PubMed
117.
Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003, 142: 402-408. 10.1067/mpd.2003.139.PubMed
118.
Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC: Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011, 217: 211-219. 10.1007/s00213-011-2270-z.
119.
Galbally M, Lewis AJ, Buist A: Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry. 2011, 45: 393-399. 10.3109/00048674.2010.549995.PubMed
120.
Mortensen J, Olsen J, Larsen H, Bendsen J, Obel C, Sørensen H: Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol. 2003, 18: 769-771.PubMed
121.
Weikum WM, Oberlander TF, Hensch TK, Werker JF: Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci. 2012, 109: 17221-17227. 10.1073/pnas.1121263109.PubMedPubMedCentral
122.
Lewis A, Galbally M, Bailey C: Perinatal mental health, antidepressants and neonatal outcomes: findings from the Longitudinal Study of Australian Children. Neonatal Paediatr Child Health Nurs. 2012, 15: 22-28.
123.
Galbally M, Snellen M, Lewis AJ: A review of the use of psychotropic medication in pregnancy. Current Opinion in Obstetrics and Gynecology. 2011, 23: 408-414. 10.1097/GCO.0b013e32834b92f3.PubMed
124.
Lewis AJ, Galbally M, Opie G, Buist A: Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry. 2010, 44: 482-487. 10.3109/00048670903559593.PubMed
125.
Galbally M, Lewis AJ, Lum J, Buist A: Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry. 2009, 43: 846-854. 10.1080/00048670903107583.PubMed
126.
Galbally M, Snellen M, Lewis AJ: A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol. 2011, Publish Ahead of Print:10.1097/GCO.1090b1013e32834b32892f32833
127.
Austin MP, Kildea S, Sullivan E: Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust. 2007, 186: 364-367.PubMed
128.
Schnaas L, Rothenberg SJ, Flores M-F, Martinez S, Hernandez C, Osorio E, Velasco SR, Perroni E: Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect. 2005, 114: 791-797. 10.1289/ehp.8552.PubMedCentral
129.
Wasserman GA, Staghezza-Jaramillo B, Shrout P, Popovac D, Graziano J: The effect of lead exposure on behavior problems in preschool children. Am J Public Health. 1998, 88: 481-486. 10.2105/AJPH.88.3.481.PubMedPubMedCentral
130.
Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL: Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol. 2001, 23: 511-518. 10.1016/S0892-0362(01)00184-2.PubMed
131.
Tong S, Baghurst PA, Sawyer MG, Burns J, McMichael AJ: Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie Cohort Study. JAMA. 1998, 280: 1915-1919. 10.1001/jama.280.22.1915.PubMed
132.
Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP: Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med. 2003, 348: 1517-1526. 10.1056/NEJMoa022848.PubMedPubMedCentral
133.
Huang PC, Su PH, Chen HY, Huang HB, Tsai JL, Huang HI, Wang SL: Childhood blood lead levels and intellectual development after ban of leaded gasoline in Taiwan: a 9-year prospective study. Environ Int. 2012, 40: 88-96.PubMed
134.
Chen A, Cai B, Dietrich KN, Radcliffe J, Rogan WJ: Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ?. Pediatrics. 2007, 119: e650-e658. 10.1542/peds.2006-1973.PubMedPubMedCentral
135.
Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, LoIacono N, Graziano JH: The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol. 2000, 22: 811-818. 10.1016/S0892-0362(00)00106-9.PubMed
136.
Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R: Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005, 113: 894-899. 10.1289/ehp.7688.PubMedPubMedCentral
137.
Baghurst PA, McMichael AJ, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ, Tong SL: Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med. 1992, 327: 1279-1284. 10.1056/NEJM199210293271805.PubMed
138.
Chiodo LM, Jacobson SW, Jacobson JL: Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol. 2004, 26: 359-371. 10.1016/j.ntt.2004.01.010.PubMed
139.
Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB: Bone lead levels and delinquent behavior. JAMA. 1996, 275: 363-369. 10.1001/jama.1996.03530290033034.PubMed
140.
Sciarillo WG, Alexander G, Farrell KP: Lead exposure and child behavior. Am J Public Health. 1992, 82: 1356-1360. 10.2105/AJPH.82.10.1356.PubMedPubMedCentral
141.
Burns JM, Baghurst PA, Sawyer MG, McMichael AJ, Tong SL: Lifetime low-level exposure to environmental lead and children's emotional and behavioral development at ages 11–13 years. The Port Pirie Cohort Study. Am J Public Health. 1999, 149: 740-749.
142.
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS: Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics. 2009, 124: e1054-e1063. 10.1542/peds.2009-0738.PubMedPubMedCentral
143.
Symeonides C, Ponsonby A-L, Vuillermin P, Anderson V, Sly P: Environmental chemical contributions to ADHD and the externalising disorders of childhood - a review of epidemiological evidence. J Environ Immunol Toxicol. 2013, 1: 92-104. 10.7178/jeit.21.
144.
Sagiv SK, Thurston SW, Bellinger DC, Amarasiriwardena C, Korrick SA: Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med. 2012, 166: 1123-1131. 10.1001/archpediatrics.2012.1286.PubMedPubMedCentral
145.
Sagiv SK, Thurston SW, Bellinger DC, Tolbert PE, Altshul LM, Korrick SA: Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol. 2010, 171: 593-601. 10.1093/aje/kwp427.PubMedPubMedCentral
146.
Wise A, Parham F, Axelrad DA, Guyton KZ, Portier C, Zeise L, Zoeller RT, Woodruff TJ: Upstream adverse effects in risk assessment: a model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans. Environ Res. 2012, 117: 90-99.PubMed
147.
Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ: Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988–2004. Pediatrics. 2009, 123: e376-e385. 10.1542/peds.2007-3608.PubMed
148.
Noren K, Meironyte D: Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20–30 years. Chemosphere. 2000, 40: 1111-1123. 10.1016/S0045-6535(99)00360-4.PubMed
149.
Zietz BP, Hoopmann M, Funcke M, Huppmann R, Suchenwirth R, Gierden E: Long-term biomonitoring of polychlorinated biphenyls and organochlorine pesticides in human milk from mothers living in northern Germany. Int J Hyg Environ Health. 2008, 211: 624-638. 10.1016/j.ijheh.2008.04.001.PubMed
150.
151.
Grandjean P, Landrigan PJ: Developmental neurotoxicity of industrial chemicals. Lancet. 2006, 368: 2167-2178. 10.1016/S0140-6736(06)69665-7.PubMed
152.
Zhu SH, Valbo A: Depression and smoking during pregnancy. Addict Behav. 2002, 27: 649-658. 10.1016/S0306-4603(01)00199-X.PubMed
153.
DiPietro JA, Novak MF, Costigan KA, Atella LD, Reusing SP: Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev. 2006, 77: 573-587. 10.1111/j.1467-8624.2006.00891.x.PubMed
154.
Way BM, Taylor SE: The serotonin transporter promoter polymorphism is associated with cortisol response to psychosocial stress. Biol Psychiatry. 2010, 67: 487-492. 10.1016/j.biopsych.2009.10.021.PubMed
155.
Davis EP, Sandman CA: The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev. 2010, 81: 131-148. 10.1111/j.1467-8624.2009.01385.x.PubMedPubMedCentral
156.
Rayen I, van den Hove DL, Prickaerts J, Steinbusch HW, Pawluski JL: Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One. 2011, 6: e24003-10.1371/journal.pone.0024003.PubMedPubMedCentral
157.
Lee HJ, Kim JW, Yim SV, Kim MJ, Kim SA, Kim YJ, Kim CJ, Chung JH: Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol Psychiatry. 2001, 6: 610-10.1038/sj.mp.4000954. 725–618PubMed
158.
Weikum WM, Brain U, Chau CM, Grunau RE, Boyce WT, Diamond A, Oberlander TF: Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front Cell Neurosci. 2013, 7: 180.PubMedPubMedCentral
159.
Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B: Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012, 169: 1165-1174.PubMed
160.
Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002, 159: 1889-1895. 10.1176/appi.ajp.159.11.1889.PubMed
161.
Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H: Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry. 2004, 184: 526-533. 10.1192/bjp.184.6.526.PubMed
162.
Jacka FN, Reavley NJ, Jorm AF, Toumbourou JW, Lewis AJ, Berk M: Prevention of common mental disorders: What can we learn from those who have gone before and where do we go next?. Aust N Z J Psychiatry. 2013, 47: 920-929. 10.1177/0004867413493523.PubMed
163.
Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A: No health without mental health. Lancet. 2007, 370: 859-877. 10.1016/S0140-6736(07)61238-0.PubMed
164.
Olds DL, Sadler L, Kitzman H: Programs for parents of infants and toddlers: recent evidence from randomized trials. J Child Psychol Psychiatr. 2007, 48: 355-391. 10.1111/j.1469-7610.2006.01702.x.
165.
Olds DL, Kitzman H, Hanks C, Cole R, Anson E, Sidora-Arcoleo K, Luckey DW, Henderson CR, Holmberg J, Tutt RA: Effects of nurse home visiting on maternal and child functioning: age-9 follow-up of a randomized trial. Pediatrics. 2007, 120: e832-e845. 10.1542/peds.2006-2111.PubMedPubMedCentral
166.
Olds DL: The nurse-family partnership: an evidence-based preventive intervention. Infant Ment Health J. 2006, 27: 5-25. 10.1002/imhj.20077.
167.
Dennis CL: Psychosocial and psychological interventions for prevention of postnatal depression: systematic review. BMJ. 2005, 331: 15-10.1136/bmj.331.7507.15.PubMedPubMedCentral
168.
Fisher JR, Wynter KH, Rowe HJ: Innovative psycho-educational program to prevent common postpartum mental disorders in primiparous women: a before and after controlled study. BMC Publ Health. 2010, 10: 432-10.1186/1471-2458-10-432.
169.
Lumley J, Austin MP, Mitchell C: Intervening to reduce depression after birth: a systematic review of the randomized trials. Int J Technol Assess Health Care. 2004, 20: 128-144.PubMed
Metadata
Title
Early life programming as a target for prevention of child and adolescent mental disorders
Authors
Andrew James Lewis
Megan Galbally
Tara Gannon
Christos Symeonides
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2014
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-12-33

Other articles of this Issue 1/2014

BMC Medicine 1/2014 Go to the issue

Research article

Elevated risk of stillbirth in males: systematic review and meta-analysis of more than 30 million births

Question and Answer

Video Q&A: Tobacco-related mortality: past, present and future. An interview with Alan Lopez

Research article

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

Research article

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

Research article

Hospital admissions in relation to body mass index in UK women: a prospective cohort study

Research article

School-based mental health intervention for children in war-affected Burundi: a cluster randomized trial